Evercore ISI Remains Cautious on Celanese Corporation (CE) Post-Q3 Earnings, Despite Broader Chemical Stock Rallies

Core Insights - Celanese Corporation is currently viewed as one of the most undervalued stocks on the NYSE, with a recent price target adjustment from Evercore ISI analyst Eric Boyes, lowering it to $45 from $75 while maintaining an In Line rating [1] - The Q3 2025 earnings report revealed a significant trading shift in the chemical sector, with approximately half of the tracked chemical stocks reducing their Q4 outlook, yet two-thirds experienced an average share price increase of 6% post-results [1] Financial Performance - In Q3, Celanese reported total revenue of $2.42 billion and earnings of $1.34 per share, focusing on enhancing cash flow, cost improvements, and top-line growth [2] - The company anticipates an EPS growth of $1 to $2 in 2026, with around half of this growth expected from cost savings and the remainder from success in the Engineered Materials pipeline, alongside a projected reduction in interest expense of $30 to $40 million [2] Strategic Initiatives - Celanese completed the sale of its Micromax business in Q3, contributing to its goal of achieving $1 billion in divestitures by 2027 [3] - The company is actively pursuing additional cost savings, expecting to realize net savings of $30 to $50 million within the Engineered Materials segment after accounting for inflation [3]